Table 3.
Clinical variables of the bipolar patient groups
| BP-acute-D (N = 20) |
BP-euth-D (N = 19) |
BP-euth-M (N = 13) |
χ2 | p | Post-hoc χ2 tests with Bonferroni-correction | |
|---|---|---|---|---|---|---|
| Bipolar Typea | 5.87 | .053 | – | |||
| Type I | 8 (44%) | 9 (47%) | 11 (85%) | |||
| Type II | 10 (56%) | 10 (53%) | 2 (15%) | |||
| Age of onset of diseaseb | 28.2 (12.5) | 27.8 (11.0) | 29.1 (10.8) | .16 | .926 | – |
| Number of inpatient staysc | 4.6 (6.2) | 3.1 (2.3) | 3.5 (2.9) | .99 | .611 | – |
| Medicationd | ||||||
| Antidepressants | 19 (95%) | 12 (63%) | 6 (46%) | 10.1 | .006** | BP-acute-D > BP-euth-M (χ2 = 10.236, p = .009) |
| Lithium | 11 (55%) | 12 (63%) | 9 (69%) | .71 | .702 | – |
| Valproate | 5 (25%) | 4 (21%) | 3 (23%) | .20 | 1 | – |
| Pregabalin | 2 (10%) | 1 (5%) | 1 (8%) | .57 | 1 | – |
| Lamotrigine | 3 (15%) | 1 (5%) | 1 (8%) | 1.10 | .837 | – |
| Antipsychotics | 18 (90%) | 7 (37%) | 10 (77%) | 13.2 | .001** | BP-acute-D > BP-euth-D (χ2 = 11.965, p = .003) |
| Benzodiazepines | 2 (10%) | 3 (16%) | - | .29 | .661 |
BP-acute-D patients in an acute depressive phase, BP-euth-D euthymic patients with a predominant depressive polarity, BP-euth-M euthymic patients with a predominant manic polarity
aNumber and percentage of patients (for two patients of the BP-acute-D group the information about the bipolar type was not available)
bMean age and SD (for one patient of the BP-acute-D group the information about the age of onset of disease was not available)
cN and SD
dNumber and percentage of patients
**p<0.01